Document:

Amended and Restated Employment Agreement

 Exhibit 10.17 
 AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS AMENDED AND RESTATED
EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 11th day of April 2011 (“Effective Date”) by and between Dais Analytic Corporation, a New York Corporation (“Company”), and Timothy N. Tangredi
(“Executive”). 
 RECITALS 
 WHEREAS, Executive entered into an employment agreement with Company dated July 28, 2008 (the “July 2008 Agreement”); and 

WHEREAS Company and Executive desire to amend and restate the July 2008 Agreement to reflect such changes as hereinafter provided; and

 WHEREAS, the Executive and Company wish to continue Executive’s employment with the Company on the terms and conditions
set forth herein. 
 NOW, THEREFORE, in consideration of the premises and mutual promises and agreement hereinafter set forth,
it is agreed as follows: 
 Article 1 Employment 

 

	 	1.1.	Company hereby employs Executive, and Executive hereby accepts such employment from Company, on the terms and conditions set forth in this Agreement.

  

	 	1.2.	Term. Subject to the provisions for termination and extension as hereinafter provided, the term (the “Term”) of this Agreement shall commence on
April 11, 2011 (the “Commencement Date”) and shall continue until the third anniversary thereof. 

  

	 	1.3.	Automatic Renewal. The Term shall automatically be extended on the second anniversary of the Commencement Date for an additional two years, and on each
subsequent anniversary of the Commencement Date thereafter for an additional one year, unless in any such case either Executive or Company delivers, at least one hundred and eighty days before such anniversary of the Commencement Date, written
notice to the other party of his or its intent not to renew or extend the Term. 

  

	 	1.4.	Termination of Existing Agreement. Effective upon the close of business on the day prior to the Commencement Date, any employment agreement by and between Company and
Executive which predates the Commencement Date is hereby terminated, except that any rights and obligations which accrue or otherwise arise prior to the Commencement Date under any such agreement shall continue to be enforceable.

 Article 2 Duties 
  

	 	2.1.	Position. Executive will continue to serve as the President and Chief Executive Officer of Company during the Term of this Agreement, and his duties hereunder in
such position shall be as set forth in the By-Laws of the Company. Any material diminution in the powers, duties and authorities of Executive set forth in the By-Laws shall not be effected without the prior written consent of the Executive.
Executive will devote substantially all of his professional time during regular business hours to the Company’s business, except that Executive will be permitted to perform charitable work and to manage his personal and other business
investments so long as such outside activities do not interfere with the performance of Executive’s duties on behalf of Company. 

  
 Page 1 of 10

	 	2.2.	Location. Executive shall be employed at the Company’s principal offices located in Odessa, Florida, subject to necessary travel on Company business as
determined by the Executive. The Company’s principal offices shall not be moved to a location that is more than 20 miles from the Company’s current principal offices without the Executive’s prior written consent.

  

	 	2.3.	Directorships; Position with Subsidiaries. During the Term of this Agreement, the Board of the Company shall use its best efforts to cause Executive to continue
to be elected as a director of the Company. Such best efforts shall include, but not be limited to, nominating Executive as part of the management slate of directors to be elected by the shareholders of the Company, endorsing the election of
Executive as a director and soliciting proxies for the election of Executive. In addition, at Executive’s request, the Company shall have Executive elected to the Board of Directors of each of its subsidiaries. 

Article 3 Compensation and Benefits 
  

	 	3.1.	Salary and Bonus. Subject to the terms and conditions set forth below, Executive will receive the following compensation for his services during his Term
of employment (beginning on the Commencement Date) 

  

	 	a.	 Base Salary. From and after the Commencement Date the Executive shall receive a base salary of $170,000 per annum. From and after the date on
which the Company obtains $10 million or more in equity or debt financing, the Executive’s base salary shall be increased to $220,000 per annum or such higher sum as the Board of Directors shall set. The base salary, as in effect from time to
time during the Term of this Agreement, shall hereinafter be referred to as the “Base Salary”. The Base Salary in effect on each anniversary date of this Agreement shall be increased by a percentage that is no less than the percentage
increase in the Consumer Price Index for the preceding twelve calendar months for the greater Palo Alto, California area. In addition, the Base salary then in effect shall be reviewed by the Board of Directors not less frequently than annually and
may be further increased by the Board in its discretion from time to time but may not be decreased without the Executive’s prior written consent. The Base Salary in effect from time to time shall be payable in accordance with the Company’s
customary payroll practices. Notwithstanding the above if the market capitalization of the Company at the end of the calendar year as measured by Bloomberg LP (or equal) is more than two times greater than the year before the Executive will be
entitled to a cash payment of 2% of the difference in capitalization from last year to the current year to be paid within sixty days of the determination which shall occur no later than January 10th of the new year. 

 

	 	b.	Bonus. Executive shall be eligible to receive an annual bonus in an amount not below 100% of his effective base salary and not exceeding 300% of his then
effective Base Salary, which bonus shall be measured by Executive’s success in meeting certain performance goals, including but not limited to revenue and gross margin goals, product roll-outs, organizational and staffing objectives, and
business development goals. The above notwithstanding the Board or the Compensation Committee may provide the Executive with a bonus commensurate with the Company’s overall large success, sale of a division, major license or distribution
arrangement, merger, or any such extraordinary event a sum greater than the 300% referenced above. The Compensation Committee of the Board of Directors shall establish such performance goals and criteria in writing at the beginning of each year of
the Term. The bonus provided for in this paragraph (b) may be modified from time to time as determined in good faith by the Compensation Committee of the Board of Directors and shall be in addition to the stock options (and/or restricted stock)
which may be earned by the Executive pursuant to Section 3.2 below or any other stock options granted to Executive. Any bonus granted pursuant to this Section 3.1(b) shall be paid within 45 days after the end of the period to which it
relates. 

  
 Page 2 of 10

	 	3.2.	Stock Options. 

  

	 	a.	Options (and/or Restricted Stock) Related to Product Introductions. For each product for which the Company commences commercial sale or licensing during the Term
and receives more than $1,000,000 of revenue during any 12 month period (“Target Revenue Amount”), the Executive, in addition to any other compensation which he may receive hereunder, shall be granted options to purchase 250,000 shares of
the Company’s Common Stock, which options shall be exercisable at a price equal to either (i) the lower of: (a) Fifty Cents ( $0.50) per share or (b) the fair market value per share of the stock on the Date of Grant as determined
in good faith by the Compensation Committee of the Board of Directors, if the Company has not conducted a secondary public offering prior to the Date of Grant (as hereinafter defined), or (ii) at an exercise price equal to 75% of the market
price of the Common Stock, if the Company has completed a secondary public offering of its Common Stock prior to the Date of Grant (with the market price to be the average of the closing sale prices during the five trading days immediately preceding
the Date of Grant of the option). Such options, as well as any other options granted to Executive during the term of his employment, shall be granted under the Company’s then existing stock option plan, shall be immediately exercisable, have a
term of ten years, shall be exercisable for up to three years after termination of employment by Executive with the Company (unless termination is for Cause, as hereinafter defined, in which event they shall expire on the date of termination), shall
have a “cashless” exercise feature, and shall be subject to such additional terms and conditions as are then applicable to options granted under such plan provided they do not conflict with the terms set forth herein. The “Date of
Grant” of any option granted pursuant to this Section 3.2 (a), shall be deemed the last business day of the calendar month in which the revenues from a product exceed the Target Revenue Amount. 

 

	 	b.	Options (and/or Restricted Stock) Related to Stock Price. In the event that the Fair Market Value (as defined below) of the Company’s Common Stock equals or
exceeds 200% of the price at which the Company sells Common Stock in the secondary public offering (adjusted for splits if needed, and herein referred to as “Target Value”) at any time during the Term, Executive shall be granted options to
purchase 500,000 shares of Common Stock at an exercise price equal to 75% of the Target Value, on terms identical to the options provided for in paragraph (a) of this Section 3.2 above. For purposes of this paragraph, “Fair Market
Value” shall mean, the average of the closing prices of the Common Stock for any five consecutive trading days, as reported by the principal exchange or other stock market on which the Common Stock is then traded. 

 

	 	3.3.	Benefits. Executive shall receive the following benefits during the Term of this Agreement: 

 

	 	a.	Health Benefits. Medical, hospital, surgical, vision, dental, long and short term disability, accidental death and/or travel insurance coverage (collectively
“Health Benefits”), as generally offered and made available to other executive officers of the Company and to the extent Executive’s age, health or other qualifications make him eligible to participate, except that the Executive shall
not be required to pay any amounts toward the premiums therefore. In the event that the Company does not offer Health Benefits to executive officers of the Company, then Company shall reimburse Executive for the premium costs of Health Benefits.

  

	 	b.	Vacation. Four weeks of paid vacation, and fifteen personal days per year. At Executive’s option, any accrued but unused vacation or personal days at the
end of a calendar year shall be payable in cash or carried over to the following year at the Executive’s election. 

  
 Page 3 of 10

	 	c.	Life Insurance. The Company shall provide term life insurance on the life of the Executive in an amount equal to 300% of the Base Salary then in effect. The
beneficiary or beneficiaries of said insurance shall be as designated in writing to the Company by Executive, and the owner of the policy shall be the Executive or his assigns. The Company shall pay all the premiums payable on such insurance and any
applicable federal and local income taxes as a result of such payment. 

  

	 	d.	Reimbursement of Expenses. Executive shall be reimbursed for all ordinary and reasonable business expenses incurred in accordance with Company’s policies
and customary practices. This includes reimbursement of up to $7,500 for one executive conference or educational venue of the Executive’s choosing. 

  

	 	e.	Transportation Allowance. In addition to expenses reimbursable pursuant to paragraph (d) above, the Company shall provide Executive with an automobile
allowance of $800 per month during the Term of this Agreement, and the Company shall reimburse Executive for the cost of insurance, repairs, gas, tolls, and maintenance associated with Executive’s automobile as well as the costs of a mobile
phone for the Executive’s use. 

  

	 	f.	Other Benefits. In addition to the benefits specifically set forth above in this Section 3.3, Executive shall be entitled to participate during the Term in
all employee benefit plans, including but not limited to the Company’s incentive compensation plan, which may be made available at the date hereof or in the future by the Company to employees serving the Company or its subsidiaries in an
executive capacity. Benefits for Executive under such plans shall be at least as great as those offered to any other employee of the Company or any of its subsidiaries but any option grant under said benefit plans shall be subject to the same terms
as those of Section 3.2 (a) with the exception that the Date of Grant shall be the date set by the Board of Directors for said grant. 

 Article 4 Termination. 
  

	 	4.1.	Termination of Employment. The Term of employment shall terminate prior to the end of the period of time specified in Section 1 immediately upon:

  

	 	a.	the death of Executive; 

  

	 	b.	the election of the Company in the event of Executive’s Disability (as defined below) during the Term of employment; 

 

	 	c.	the election of the Company for Cause (defined below); 

  

	 	d.	the election of the Company without Cause; 

  

	 	e.	the resignation of Executive for Good Reason (as defined below); 

  

	 	f.	the resignation of Executive without Good Reason; or 

  

	 	g.	the resignation of Executive within one year following a Change in Control of the Company (as defined below). 

  
 Page 4 of 10

	 	4.2.	 Procedure. The decision to terminate Executive pursuant to (b), (c) or (d) shall require the affirmative vote of sixty-six and two
third percent (66 2/3rd %) of the disinterested directors
of the Board. Except as otherwise provided in this Article 4, upon the occurrence of any event described in (a) through (h) above, Executive’s employment shall terminate and the Company shall have no further obligation to Executive
hereunder except to pay to Executive (or his estate, as the case may be), within ten days following the date of termination, his accrued but unpaid Base Salary, bonus and accrued vacation pay, less standard withholdings for tax and social security
purposes, plus any unreimbursed expenses. 

  

	 	4.3.	Definitions. 

  

	 	a.	“Good Reason” means either (i) a material breach by Company of this Agreement that Company fails to cure within twenty days after receiving written
notice from Executive of such breach or (ii) Company’s failure to pay any compensation due and owing to Executive within ten days after receiving written notice from Executive that such payment is due. 

 

	 	b.	“Cause” means: 

  

	 	(i)	a material breach by Executive of this Agreement that Executive fails to cure within thirty days after receiving written notice from Company of such breach;

  

	 	(ii)	Executive’s failure to follow reasonable, lawful orders or directions of the Board, after Executive has been given written notice of his default and has not
followed such lawful orders or directions of the Board within thirty days of receiving such notice; 

  

	 	(iii)	Executive’s willful misconduct, dishonesty or reckless disregard of his responsibilities to Company, after Executive has been given written notice of his default
and has not cured such conduct within thirty days of receiving such notice; 

  

	 	(iv)	Executive’s conviction or plea of nolo contendere or the equivalent in respect of either a felony or a misdemeanor involving moral turpitude but excluding, in any
event, vehicular infractions; or 

  

	 	(v)	Executive’s material violation of any written major Company policy previously communicated to Executive, after Executive has been given written notice of his
default and has not cured such violation within thirty days of receiving such notice. 

  

	 	c.	“Disability” means a physical or mental illness, injury or condition that prevents Executive from performing his essential duties under this Agreement, even
with reasonable accommodation, for at least ninety consecutive calendar days or for at least one hundred and twenty calendar days, whether or not consecutive, in any one hundred and eighty calendar day period. 

 

	 	d.	“Change in Control of the Company” shall be deemed to have occurred if any one of the following occurs: 

 

	 	(i)	The acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 33% or more of either the then outstanding shares of Common Stock or the combined voting power of
the then outstanding voting securities of the Company having general voting power in electing the Board of Directors of the Company; 

  
 Page 5 of 10

	 	(ii)	Individuals who, as of the date hereof, constitute the Board of Directors of the Company (the “Incumbent Board”) cease for any reason to constitute at least a
majority of the Board of the Directors; or 

  

	 	(iii)	Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company or of the sale or other disposition of all or substantially all of
the assets of the Company, or of a reorganization, merger or consolidation with respect to which the individuals and entities who were the respective beneficial owners of the outstanding Common Stock and voting securities of the Company immediately
prior to such reorganization, merger or consolidation do not, immediately following such reorganization, merger or consolidation, beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of Common Stock
and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the entity resulting from such reorganization, merger or consolidation, as the case may be. 

 

	 	4.4.	Severance Pay and Other Benefits Upon Termination In Certain Circumstances. 

 

	 	a.	Termination By Company Due to Disability, Termination by Company Without Cause, or Resignation By Executive for Good Reason. In the event Executive’s employment is
terminated by the Company under section 4.1(b) or (d) or the Executive resigns for Good Reason under section 4.1(f), the Executive shall be entitled to the following: 

 

	 	(i)	Severance Pay. The Company shall pay to Executive within ten days after such termination or resignation an amount equal to the sum of: 

 

	 	(A.)	the greater of 300% of the Base Salary then in effect for Executive or $675,000, plus 

 

	 	(B.)	the cash and equity (options and/or restricted stock) bonus, if any, awarded to Executive for the most recent year pursuant to Section 3.1(b) hereof;

  

	 	(ii)	Continuation of Benefits. Company shall continue to provide Executive the benefits set forth in Section 3.3 of this Agreement until two years following termination
of Executive’s employment, and shall continue to offer any of such benefits to Executive beyond such two year period to the extent required by COBRA or similar statute which may then be in effect; 

 

	 	(iii)	Vesting of Options. All stock options, to the extent they were not exercisable at the time of termination of employment, shall become exercisable in full;

  

	 	(iv)	Cancellation of Indebtedness. Any indebtedness of Executive to the Company shall thereupon be cancelled and of no further force and effect, and the Company shall pay to
Executive, within ten days following receipt of a written demand therefor, an amount sufficient to offset any income taxes or other taxes resulting from such cancellation. 

 

	 	b.	Death. In the event of termination of employment as a result of the death of Executive, the provisions of (a)(i) and (a)(iv) of this Section 4.3 shall also be
applicable. Additionally, all stock options awarded to Executive, to the extent not previously exercised, shall be deemed to have been exercised by Executive on the day immediately before Executive’s death. 

  
 Page 6 of 10

	 	c.	Change in Control of the Company. In the event that Executive elects to resign from employment under Section 4.1(g) of this agreement, he shall be entitled to the
following: 

  

	 	(i)	Severance Pay. The Company shall pay to Executive within the later of ten days following the date on which the Change in Control occurs or the date on which he gives
notice of his election to resign from employment a lump-sum payment equal to two and one half times the sum of: 

  

	 	(A.)	the greater of the Base Salary then in effect for Executive or $220,000, plus 

 

	 	(B.)	the cash bonus and equity (options or restricted stock) if any, awarded to Executive for the most recent year pursuant to Section 3.1(b) hereof;

  

	 	(ii)	In addition, the provisions of (a) (ii), (a) (iii) and (a) (iv) of this Section 4.3 shall also be applicable. 

Article 5 Intellectual Property 
  

	 	5.1.	Intellectual Property. Any and all intellectual property right, title and interest in works created or generated by Executive, whether alone or with others,
during the Term within the scope of his employment, vests exclusively in, and will be the property of, the Company. Works shall be considered within the scope of the Executive’s employment where the works (i) are created in whole or in
part within the confines of Company’s facilities during business hours or (ii) are created in whole or in part using Company facilities, materials, processes, equipment or supplies, where such intellectual property works reasonably relate
to Company’s actual or intended business. Executive will execute any reasonable documents necessary to transfer any such intellectual property to Company, including, at Company’s expense, all patent applications and any continuations,
continuations in part, divisional, reexaminations, reissues or foreign counterparts thereof. 

 Article 6
Non-Competition; Non-Solicitation; Confidentiality 
  

	 	6.1.	Non-Competition. Executive agrees that (a) during the Term of this Agreement and (b) for a period of two years after termination of Executive’s
employment with the Company for any reason, Executive will not, without the prior written consent of Company, directly or indirectly, have an interest in, be employed by or be connected with, as an Executive, consultant, officer, director, partner,
member, stockholder or joint venture, any person or entity owning, managing, controlling, operating or otherwise participating or assisting in any business that is in competition with Company’s core nanotechnology materials. This does not
preclude the Executive from pursuing healthcare related uses. Notwithstanding the foregoing, Executive’s ownership of greater than five percent (5%) of the issued and outstanding securities of any class of a corporation listed on a
national securities exchange or designated as national market system securities on an inter-dealer quotation system by the National Association of Securities Dealers, Inc. shall not be a violation of this Agreement. 

 

	 	6.2.	Non-Solicitation. Executive agrees that (a) upon termination of Executive’s employment with the Company for any reason and (b) for a period of one
year thereafter, Executive will not solicit or hire any person employed by Company at any time. The foregoing restriction shall not apply to any Company employee whose annual salary is less than $75,000 or who has ceased to be employed by Company
for at least six months. 

  

	 	6.3.	Confidentiality. 

  

	 	a.	Except as may be required to be disclosed by Executive under applicable law (including any applicable judicial or governmental regulation, directive, requirement or
order) and except as required in connection with the performance of his duties under this Agreement, Executive shall keep confidential and shall not disclose, directly or indirectly, to any other person (other than to Company’s other employees
and/or agents in connection with such party’s performance of its obligations to Company) any Confidential Information (defined below), and shall not use for his personal benefit or for that of any other person any Confidential Information. This
Section 6.3 shall not apply to Company information which: (i) Executive knows at the time of disclosure, free of any obligation to keep it confidential as evidenced by written records; (ii) at the time of disclosure is in the public
domain; (iii) is disclosed to Executive by a third party that did not acquire such information under any obligation of confidence; (iv) is required to be disclosed by any court of competent jurisdiction provided that prior written notice
of such disclosure is afforded to Company; (v) is or becomes generally available to the public through no fault of Executive. 

  
 Page 7 of 10

	 	b.	For purposes of this Agreement, the term “Confidential Information” means trade secrets, discoveries, ideas, concepts, know-how, techniques, designs,
specifications, drawings, diagrams, data, computer programs, business activities and operations, budgets, salaries, financial statements, prices, costs and other business information of or relating to Company or any subsidiaries of Company that may
from time to time exist. 

  

	 	c.	Upon the termination of Executive’s employment for any reason whatsoever, Executive shall deliver to Company all tangible materials embodying the Confidential
Information, including any documentation, records, listings, notes, data, sketches, drawings, memoranda, models, accounts, reference materials, samples, machine-readable media and equipment which in any way relate to the Confidential Information.
Executive shall not retain any copies of any of the above materials. 

  

	 	6.4.	Injunctive Relief. Executive acknowledges that he has substantial knowledge and expertise in, and personal relationships affecting, the operations, business contacts,
trade secrets, customer lists, marketing, business strategies and processes and other confidential matters of critical significance to the conduct of the Company’s business and its future prospects. Executive, therefore, agrees and consents
that, in addition to any other remedies that may be available to Company, Company shall be entitled to specific performance by temporary as well as permanent injunction to prevent a breach or contemplated breach by Executive of any of the covenants
or agreements in Sections 6.1, 6.2 or 6.3. 

 Article 7 Indemnification 

 

	 	7.1.	Indemnification. During the term of this Agreement, and subsequent thereto with respect to any claim arising out of or in connection with his employment with the
Company or any subsidiary of the Company, the Company shall indemnify and hold Executive harmless from all claims and liability, loss or damage (including but not limited to judgments, fines and amounts paid in settlement), asserted against
Executive or incurred by Executive, including reasonable attorneys fees and costs of investigation (the “Indemnification”). The Indemnification provided for herein shall be in addition to and not in substitution of any and all rights to
indemnification which Executive may be entitled to under the laws of the State of Florida or the Certificate of Incorporation and By-laws of the Company. To the extent permitted under the laws of the State of Florida, and the Company’s
Certificate of Incorporation and By-Laws, all expenses, including reasonable attorneys fees, incurred by Executive in defending any civil, criminal, administrative or investigative action, shall upon request by Executive, be paid and advanced by the
Company in advance of the final disposition of such action, suit or proceeding. 

  

	 	7.2.	Director and Officers Liability Insurance. During the Term, unless the Executive otherwise consents, the Company will maintain directors’ and officers’
liability insurance in an amount not less than $5,000,000, and Executive shall at all times be one of the named insured under such coverage. 

  
 Page 8 of 10

 Article 8 Miscellaneous. 

 

	 	8.1.	Governing Law. Florida law without regard to the conflicts of laws principles thereof shall govern this Agreement. 

 

	 	8.2.	Non-Contravention. Executive represents and warrants that the execution, delivery and performance of this Agreement do not and will not contravene, conflict with
or otherwise violate the terms of any written or oral agreement among Executive and one or more third parties. 

  

	 	8.3.	Arbitration. Disputes between the parties arising under or with respect to this Agreement shall be submitted to arbitration in Hillsborough County, Florida by a
single arbitrator under the rules of the American Arbitration Association, and the arbitration award shall be binding upon the parties and enforceable in any court of competent jurisdiction. The cost of arbitration, including counsel fees, shall be
borne by the Company unless the arbitrator determines that the Executive’s position was frivolous and without reasonable foundation. 

  

	 	8.4.	Notices. Any notice or communication to be given under the terms of this Agreement shall be in writing and delivered in person or deposited, certified or
registered, in the United States mail, postage prepaid, addressed as follows: 

  

							
	If to Company:	  	Dais-Analytic Corporation	 	If to Executive:	  	Mr. Timothy N. Tangredi
		  	11552 Prosperous Drive	 		  	10416 Pontofino Circle
		  	Odessa, Florida 33556	 		  	Trinity, FL 34655
		  	Attn: Board of Directors	 		  	

 or at such other address as either party may from time to time designate by notice hereunder. Notices
shall be effective upon delivery in person or, if mailed, at midnight on the third business day after the date of mailing. 
  

	 	8.5.	Modifications and Amendments. This Agreement shall not be modified, altered or amended except by a written agreement signed by the parties hereto.

  

	 	8.6.	Entire Agreement. This Agreement together with the documents referred to herein or contemplated hereby constitute and embody the full and complete understanding
and agreement of the parties hereto with respect to the subject matter hereof and supersede all prior understandings or agreements whether oral or in writing with respect to the subject matter hereof. 

 

	 	8.7.	Benefit and Binding Effect. This Agreement shall be binding upon and inure to the benefit of Company and its successors and assigns, including any corporation,
person or other entity which may acquire all or substantially all of the business of Company or any other corporation with or into which Company is consolidated or merged, and Executive and his heirs, executors, administrators and legal
representatives, provided, however, that the obligations of Executive hereunder may not be delegated or assigned. 

  

	 	8.8.	Severability. If any portion of this Agreement may be held to be invalid or unenforceable for any reason whatsoever, it is agreed that said invalidity or
unenforceability shall not affect the other portions of this Agreement and that the remaining covenants, terms and conditions, or portions thereof, shall remain in full force and effect, and any court of competent jurisdiction may so modify the
objectionable provisions as to make it valid, reasonable and enforceable 

  
 Page 9 of 10

	 	8.9.	Headings; Interpretation. The section headings used herein are for convenience and reference only and are not intended to define, limit or describe the scope or
intent of any provision of this Agreement. When used in this Agreement, the term “including” shall mean without limitation by reason of enumeration. Words used herein in the singular shall include the plural. 

 

	 	8.10.	Waiver. The failure of either party to insist, in any one or more instances, upon strict performance of any of the terms or conditions of this Agreement shall
not be construed as a waiver or a relinquishment of any right granted hereunder or of the future performance of any such term, covenant or condition, but the obligations of either party with respect thereto shall continue in full force and effect.

  

	 	8.11.	Counterparts. This Agreement may be executed in any number of counterparts, each of whom shall be deemed a duplicate original. 

In Witness Whereof, the parties have executed this Agreement as of the date first written above. 

 

							
	EXECUTIVE:	 		 	DAIS ANALYTIC CORPORATION
				
	 /s/ Timothy N. Tangredi
	 		 	By:	 	 /s/ Robert W. Schwartz

	Timothy N. Tangredi	 		 	Robert W. Schwartz
		 		 	Member – Board of Directors

  
 Page 10 of 10Amended and Restated Employment Agreement

 Exhibit 10.18 
 AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS
AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 8th day of April 2011 (“Effective Date”) by and between Dais Analytic Corporation, a New York Corporation (“Company”), and Patricia K. Tangredi (“Employee”). 

RECITALS 
 WHEREAS, Employee entered into an employment agreement with Company dated November 2008 (the “November 2008 Agreement”); and 

WHEREAS Company and Employee desire to amend and restate the November 2008 Agreement to reflect such changes as hereinafter provided; and

 WHEREAS, the Employee and Company wish to continue Employee’s employment with the Company on the terms and conditions
set forth herein. 
 NOW, THEREFORE, in consideration of the premises and mutual promises and agreement hereinafter set forth,
it is agreed as follows: 
 Article 1 Employment 

 

	1.1.	Company hereby employs Employee, and Employee hereby accepts such employment from Company, on the terms and conditions set forth in this Agreement.

  

	1.2.	Term. Subject to the provisions for termination and extension as hereinafter provided, the term (the “Term”) of this Agreement shall commence on
April 8, 2011 (the “Commencement Date”) and shall continue until the fourth anniversary thereof. 

  

	1.3.	Automatic Renewal. The Term shall automatically be extended on the fourth anniversary of the Commencement Date for one year, and on each subsequent anniversary
of the Commencement Date thereafter for an additional one year, unless in any such case either Employee or Company delivers, at least one hundred and eighty days before such anniversary of the Commencement Date, written notice to the other party of
her or its intent not to renew or extend the Term. 

  

	1.4.	Termination of Existing Agreement. Effective upon the close of business on the day prior to the Commencement Date, any employment agreement by and between
Company and Employee which predates the Commencement Date is hereby terminated, except that any rights and obligations which accrue or otherwise arise prior to the Commencement Date under any such agreement shall continue to be enforceable.

 Article 2 Duties 
  

	2.1.	Position. During the Term of this Agreement the Employee shall serve as General Counsel for the Company, shall report to the President of the Company, and,
subject to the direction of the Board of Directors and the Company’s officers designated by the Board of Directors, shall perform and discharge well and faithfully the duties which may be assigned her from time to time by Company in connection
with the conduct of its business. 

  

	2.2.	Location. Executive shall be employed at the Company’s principal offices located in Odessa, Florida, subject to necessary travel on Company business.

  

	2.3.	Commitment. The Employee shall be available to advise the Company on daily and strategic issues as needed or requested by the President and the Board of
Directors. 

  
 Page 1 of 8

 Article 3 Compensation and Benefits 

 

	3.1.	Salary and Bonus. Subject to the terms and conditions set forth below, Executive will receive the following compensation for her services during the Term
of employment: 

  

	 	a.	Base Salary. Employee shall receive a salary of $120,000 per annum payable in twelve equal monthly installments. After the completion of a successful Initial
Public Offering (defined as raising $10M or more in new capital), Employee’s salary shall be increased to $150,000 per annum. Any increase of salary beyond that specifically enumerated in this section shall be the sole prerogative of the
Company and shall be effective with the commencement of the first pay period following the date of Company’s written notification to Employee of the increase. 

 

	 	b.	Patent Award. Employee shall be eligible for a one-time payment of $5,000 for each United States patent (“Patent”) of which Employee is the inventor of
the intellectual property described in the Patent. The aforementioned payment shall be due and payable only if the Patent is issued by the United States Patent Office the Patent has been assigned to Company by all its inventors, and the Intellectual
Property, which is the subject of the Patent, is employed by the Company in its product line (“Patent Conditions”). The determination as to whether the Employee is an inventor shall be made in accordance with the United States Patent
Office rules pertaining to the definition of inventorship. Any payment due hereunder shall be made in the quarter following the date all Patent Conditions have been met. Any bonus granted pursuant to this Section 3.1(b) shall be paid within 70
days after the end of the period to which it relates. 

  

	3.2.	Benefits. Employee shall receive the following benefits during the Term of this Agreement. 

 

	 	a.	Vacation; Sick Days. Employee shall be entitled to four weeks of paid vacation per year plus ten personal days At Employee’s option, Employee may carry any
accrued but unused vacation or sick days at the end of a calendar year over to the following year. 

  

	 	b.	Health Benefits. The Company will pay 50% of the regular Employee portion of her Health Care costs, and she shall be entitled to medical, hospital, surgical,
vision, dental, long and short term disability, accidental death and/or travel insurance coverage (collectively “Health Benefits”), as generally offered and made available to other executive officers of the Company and to the extent
Executive’s age, health or other qualifications make her eligible to participate. 

  

	 	c.	Reimbursement of Expenses. Executive shall be reimbursed for all ordinary and reasonable business expenses incurred in accordance with Company’s policies
and customary practices. 

  

	 	d.	Stock Options (or similar incentive vehicle such as grant of restricted stock). Regardless of any other provision herein the Employee shall be granted a minimum
of 50,000 stock options per year at the end of each year or on the annual anniversary of this agreement whichever is mutually acceptable to both Parties. An additional grant of stock options to Employee whether made under any existing or future
Stock Option Plan the Company has or may institute, shall be made at the sole discretion of Company. If an additional grant of stock options to Employee is made, it may be based upon, but not limited to, Company meeting all performance goals set for
the year of the grant, the performance evaluation of the sector under Employee’s management, and Employee’s individual performance evaluation for the year. In determining sector and individual performance for a given year Company shall
consider, in addition to any other criteria it deems relevant, whether Employee has met all performance goals established for her sector and for Employee herself in the year of the grant. Any such options shall be granted under Company’s then
existing stock option plan, shall be immediately exercisable, shall have a term of ten years, shall be exercisable for up to three years after termination of or resignation from Employment (unless termination is for Cause, in which event they shall
expire on the date of termination), and shall be subject to such additional terms and conditions as are then applicable to options granted under such plan provided they do not conflict with the terms set forth herein. 

 

	 	e.	Other Benefits. In addition to the benefits specifically set forth above in this Section 3.2, Executive shall be entitled to participate during the Term in
such other employee benefit plans, including but not limited to the Company’s incentive compensation plan, which may be made available at the date hereof or in the future by the Company, to the extent that her position, tenure, salary, age,
health, and other qualifications make her eligible to participate, subject to all applicable rules and regulations. Employee shall be deemed an executive to the extent that such designation is applicable to benefits offered pursuant to any
Company-sponsored health or insurance benefit plans. 

  
 Page 2 of 8

 Article 4 Termination. 

 

	4.1.	Termination of Employment. The Term of employment shall terminate prior to the end of the period of time specified in Section 1 immediately upon:

  

	 	a.	the death of Executive; 

  

	 	b.	the election of the Company in the event of Executive’s Disability (as defined below) during the Term of employment; 

 

	 	c.	the election of the Company for Cause (defined below); 

  

	 	d.	the election of the Company without Cause; 

  

	 	e.	the resignation of Executive for Good Reason (as defined below); 

  

	 	f.	the resignation of Executive without Good Reason; or 

  

	 	g.	the resignation of Executive within six months following a Change in Control of the Company (as defined below). 

 

	4.2.	Procedure. Except as otherwise provided in this Article 4, upon the occurrence of any event described in (a) through (h) above, Executive’s
employment shall terminate and the Company shall have no further obligation to Executive hereunder except to pay to Executive (or her estate, as the case may be), within ten days following the date of termination or resignation, her accrued but
unpaid Base Salary, bonus and accrued vacation pay, less standard withholdings for tax and social security purposes, plus any unreimbursed expenses. 

  

	4.3.	Definitions. 

  

	 	a.	“Good Reason” means either (i) a material breach by Company of this Agreement that Company fails to cure within fifteen days after receiving written
notice from Executive of such breach or (ii) Company’s failure to pay any compensation due and owing to Executive within ten days after receiving written notice from Executive that such payment is due. 

 

	 	b.	“Cause” means: 

  

	 	(i)	a material breach by Executive of this Agreement that Executive fails to cure within thirty days after receiving written notice from Company of such breach;

  

	 	(ii)	Executive’s failure to follow reasonable, lawful orders or directions of the Board, after Executive has been given written notice of her default and has not
followed such lawful orders or directions of the Board within thirty days of receiving such notice; 

  

	 	(iii)	Executive’s willful misconduct, dishonesty or reckless disregard of her responsibilities to Company, after Executive has been given written notice of her default
and has not cured such conduct within thirty days of receiving such notice; 

  

	 	(iv)	Executive’s conviction or plea of nolo contendere or the equivalent in respect of either a felony or a misdemeanor involving moral turpitude but excluding, in any
event, vehicular infractions; or 

  

	 	(v)	Executive’s material violation of any written major Company policy previously communicated to Executive, after Executive has been given written notice of her
default and has not cured such violation within thirty days of receiving such notice. 

  

	 	c.	“Disability” means a physical or mental illness, injury or condition that prevents Executive from performing her essential duties under this Agreement, even
with reasonable accommodation, for at least ninety consecutive calendar days or for at least one hundred and twenty calendar days, whether or not consecutive, in any one hundred and eighty calendar day period. 

 

	 	d.	“Change in Control of the Company” shall be deemed to have occurred if any one of the following occurs: 

 

	 	(i)	The acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 33% or more of either the then outstanding shares of Common Stock or the combined voting power of
the then outstanding voting securities of the Company having general voting power in electing the Board of Directors of the Company; 

  
 Page 3 of 8

	 	(ii)	Individuals who, as of the date hereof, constitute the Board of Directors of the Company (the “Incumbent Board”) cease for any reason to constitute at least a
majority of the Board of the Directors; or 

  

	 	(iii)	Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company or of the sale or other disposition of all or substantially all of
the assets of the Company, or of a reorganization, merger or consolidation with respect to which the individuals and entities who were the respective beneficial owners of the outstanding Common Stock and voting securities of the Company immediately
prior to such reorganization, merger or consolidation do not, immediately following such reorganization, merger or consolidation, beneficially own, directly or indirectly, more than 50% of, respectively, the then outstanding shares of Common Stock
and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the entity resulting from such reorganization, merger or consolidation, as the case may be. 

 

	4.4.	Severance Pay and Other Benefits Upon Termination In Certain Circumstances. 

 

	 	a.	Termination By Company Due to Disability, Termination by Company Without Cause, or Resignation By Executive for Good Reason. In the event Executive’s
employment is terminated by the Company under section 4.1(b) or (d) or the Executive resigns for Good Reason under section 4.1(f), the Executive shall be entitled to the following: 

 

	 	(i)	Severance Pay. The Company shall pay to Executive within ten days after such termination or resignation an amount equal to the greater of the Base Salary then in effect
for Executive or $150,000; 

  

	 	(ii)	Continuation of Benefits. Company shall continue to provide Executive the medical benefits set forth in Section 3.2 of this Agreement for one year after such
termination or resignation. Company shall continue to offer any of such benefits to Executive beyond such one-year period to the extent required by COBRA or similar statute which may then be in effect; 

 

	 	(iii)	Vesting of Options. All stock options granted to Employee at any time during the Term shall become exercisable in full and shall remain exercisable for a period of
three years following the date of termination or resignation. 

  

	 	b.	Death. In the event of termination of employment as a result of the death of Executive, the provisions of (a)(i) and (a)(iii) of this Section 4.4 shall also
be applicable as well as allowing the Estate to exercise the vested options at will for up to three years after the Employee’s death. 

  

	 	c.	Change in Control of the Company. In the event that Employee elects to resign from employment under Section 4.1(g) of this agreement, she shall be entitled
to the following: 

  

	 	(i)	Severance Pay. The Company shall pay to Executive within the later of ten days following the date on which the Change in Control occurs or the date on which she gives
notice of her election to resign from employment a lump-sum payment equal to three times the sum of the greater of the Base Salary then in effect for Executive or $450,000. 

 

	 	(ii)	In addition, the provisions of (a) (ii) and (a) (iii) of this Section 4.4 shall also be applicable. 

Article 5 Intellectual Property 
  

	5.1.	Intellectual Property. 

  

	 	a.	General Provisions. Employee acknowledges that the Company possesses and will continue to possess information that has been created, discovered, developed, or
otherwise become known to the Company (including, without limitation, information created, discovered, developed, or made known by or to the Employee during the period of or arising out of the Employee’s relationship with the Company) and/or in
which property rights have been assigned or otherwise conveyed to the Company, which information has commercial value in the business in which the Company is or may become engaged. All of the aforementioned information is hereinafter called
“Intellectual Property”. By way of illustration, but not limitation, Intellectual Property includes, whether or not patentable, trade secrets, processes, developments, ideas, structures, formulas, data, know-how, improvements,
modification, inventions, product concepts, techniques, marketing plans, strategies, forecasts, customer lists, information regarding products, designs, methods, systems, software programs, copyrightable works, discoveries, trademarks, copyrights
works of authorship, projects, plans and proposals, information about the Company’s Employees and/or consultants (including, without limitation, the compensation, job responsibilities and job performance of such Employees and/or consultants).
For the purpose of this Agreement inventions shall include, but not be limited to, discoveries, concepts, and ideas, whether patentable or not, including but not limited to, devices, processes, methods, formulae, designs, techniques, and any
improvements or modifications to the foregoing. 

  
 Page 4 of 8

	 	b.	Ownership of Intellectual Property. All Intellectual Property shall be the sole property of the Company and its assigns, and the Company and its assigns shall be
the sole owner of all patents, copyrights and other rights in connection therewith. The Employee hereby assigns to the Company or to any person, or entity designated by the Company, any and all rights and interest the Employee has or may acquire to
Intellectual Property made or conceived by the Employee, solely or jointly, or in whole or in part, during or before the term hereof (but after May 15, 2000). Any Intellectual Property create and/or reduced to practice by the Employee within
one year following the termination of her employment shall be presumed to have been created and/or reduced to practice under this Agreement unless proven otherwise. At all times both, before and after the term of this Agreement and after its
termination, Employee agrees to keep in confidence and trust all Intellectual Property and anything directly or indirectly relating to it. The Employee will not during or after the term of her employment by the Company, in whole or in part,
disclose, publish or make accessible such Intellectual Property which Employee may now possess, may obtain during or after employment or may create prior to the end of her employment, to any person, firm, corporation, association or other entity for
any reason or purpose whatsoever, nor shall the Employee make use of any such Intellectual Property for her own purposes or for the benefit of any person, firm, corporation or other entity (except the Company) under any circumstances during or after
the term of her employment. 

  

	 	c.	Disclosure of Intellectual Property. Employee will promptly disclose to the Company, or any persons designated by it, all Intellectual Property made or conceived
or reduced to practice or learned or proposed by Employee, either alone or jointly with others, during the period of this Agreement which are in any way related to or useful in the actual, anticipated or potential businesses of the Company, or the
result of tasks assigned to the Employee by the Company or resulting from use of premises or equipment owned, leased or contracted for by the Company. 

  

	 	d.	Assignment of and Assistance With Regard To Intellectual Property. Employee hereby assigns to the Company any rights the Employee may have or acquire in all
Intellectual Property and agrees that all Intellectual Property shall be the sole property of the Company and its assigns, and the Company and its assigns shall be the sole owner of all patents, copyrights and other rights in connection therewith.
Employee further agrees to assist the Company in every proper way (but at the Company’s expense) to obtain and from time to time enforce patents, copyrights or other rights on said Intellectual Property in any and all countries, and to that end
Employee will execute all documents necessary: 

  

	 	(i)	To apply for, obtain and vest in the name of the Company (unless the Company otherwise directs) letters patent, copyrights or other analogous protection in any country
throughout the world and when so obtained or vested to renew and restore the same; and 

  

	 	(ii)	To defend, at the Company’s expense, any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications for
revocation of such letters patent, copyright or other analogous protection. 

  

	 	e.	Designation of Attorney-in-Fact. In the event the Company is unable, after reasonable effort, to secure Employee’s signature on any letters patent,
copyright or other analogous protection relating to Intellectual Property because of the Employee’s physical or mental incapacity the Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as
Employee’s agent and attorney-in-fact, to act for and in Employee’s behalf and stead to execute and file any such application or applications and to do all other lawfully permitted acts to further the prosecution and issuance of letters
patent, copyright or other analogous protection thereon with the same legal force and effect as is executed by Employee. For all other reasons of disagreement the parties agree to third party arbitration to be paid for equally by both parties.
Employee’s obligation to assist the Company in obtaining and enforcing patents and copyrights for Intellectual Property in any and all countries shall continue beyond the termination of this Agreement, but the Company shall compensate the
Employee at a reasonable and customary rate after such termination for time actually spent by the Employee at the Company’s request on such assistance. 

  
 Page 5 of 8

	 	f.	Work for Hire. Employee acknowledges that all original works of authorship which are made by her (solely or jointly with others) within the scope of this
Agreement and which are protectable by copyright are being created at the instance of the Company and are “works for hire”, as that term is defined in the United States Copyright Act (17 USC Section 101). If such laws are inapplicable
or in the event that such works, or any part thereof, are determined by a court of competent jurisdiction not to be a work made for hire under the United States copyright laws, this Agreement shall operate as an irrevocable right, title and interest
(including, without limitation all rights in and to the copyrights throughout the world, including the right to prepare derivative works and the right to all renewals and extensions) in the Works in perpetuity. 

Article 6 Non-Competition; Non-Solicitation; Confidentiality 

 

	6.1.	Non-Competition. Executive agrees that (a) during the Term of this Agreement and (b) for a period of two years after termination of Executive’s
employment with the Company for any reason, Executive will not, without the prior written consent of Company, directly or indirectly, have an interest in, be employed by or be connected with, as an Executive, consultant, officer, director, partner,
member, stockholder or joint venture, any person or entity owning, managing, controlling, operating or otherwise participating or assisting in any business that is in competition with Company’s business. Notwithstanding the foregoing,
Executive’s ownership of greater than five percent of the issued and outstanding securities of any class of a corporation listed on a national securities exchange or designated as national market system securities on an inter-dealer quotation
system by the National Association of Securities Dealers, Inc. shall not be a violation of this Agreement. 

  

	6.2.	Non-Solicitation. Executive agrees that (a) upon termination of Executive’s employment with the Company for any reason and (b) for a period of one
year thereafter, Executive will not solicit or hire any person employed by Company at any time for a one-year period. The foregoing restriction shall not apply to any Company employee whose salary is less than $50,000 or who has ceased to be
employed by Company for at least six months. 

  

	6.3.	Confidentiality. 

  

	 	a.	Definition of Confidential Information. For purposes of this Agreement, “Confidential Information” means any and all information disclosed or made
available to the Employee or known to the Employee as a direct or indirect consequence of or through her relationship with the Company and not generally known in the industry in which the Company is or may become engaged including, but not limited
to, information relating to trade secrets, discoveries, ideas, concepts, know-how, techniques, designs, specifications, drawings, diagrams, data, computer programs, business activities and operations, budgets, salaries, financial statements, prices,
costs, and other business information of or relating to Company or any subsidiaries of Company that may from time to time exist. 

  

	 	b.	Non-Disclosure of Confidential Information. The Employee recognizes and acknowledges that the Company’s Confidential Information as defined below, as it may
exist from time to time, is a valuable, special and unique asset of the Company’s business, access to and knowledge of which are essential to the performance of the Employees duties hereunder. The Employee will not during or after the term of
her employment by the Company, in whole or in part, directly or indirectly, disclose, publish or make accessible such Confidential Information which Employee may now possess, may obtain during or after employment or may create prior to the end of
her employment, to any person, firm, corporation, association or other entity for any reason or purpose whatsoever (excluding court orders or subpoenas), nor shall the Employee make use of any such property for her own purposes or for the benefit of
any person, firm, corporation or other entity (except the Company) under any circumstances during or after the term of her employment, provided that after the term of her employment these restrictions shall not apply to such Confidential Information
which is then in the public domain (provided that the Employee was not responsible, directly or indirectly, for such Confidential Information entering the public domain without the Company’s consent). The Employee agrees to hold in trust and
confidence, as the Company’s property, all Confidential Information, in any way relating to the Company’s business and affairs, whether made by her or otherwise coming into her possession. 

  
 Page 6 of 8

	 	c.	Return of Confidential Information. Immediately after the Term of employment ends, regardless of the reason therefor, Employee shall deliver to Company all
tangible materials embodying the Confidential Information, including any documentation, records, listings, notes, data, sketches, drawings, memoranda, models, accounts, reference materials, samples, machine-readable media and equipment which in any
way relate to the Confidential Information. Employee shall not retain any copies of any of the above materials. 

  

	6.4.	Injunctive Relief. Executive acknowledges that he has substantial knowledge and expertise in, and personal relationships affecting, the operations, business
contacts, trade secrets, customer lists, marketing, business strategies and processes and other confidential matters of critical significance to the conduct of the Company’s business and its future prospects. Executive, therefore, agrees and
consents that, in addition to any other remedies that may be available to Company, Company shall be entitled to specific performance by temporary as well as permanent injunction to prevent a breach or contemplated breach by Executive of any of the
covenants or agreements in Sections 6.1, 6.2 or 6.3. 

 Article 7 Indemnification 

 

	7.1.	Indemnification. During the term of this Agreement, and subsequent thereto with respect to any claim arising out of or in connection with his employment with the
Company or any subsidiary of the Company, the Company shall indemnify and hold Executive harmless from all claims and liability, loss or damage (including but not limited to judgments, fines and amounts paid in settlement), asserted against
Executive or incurred by Executive, including reasonable attorneys fees and costs of investigation (the “Indemnification”) The Indemnification provided for herein shall be in addition to and not in substitution of any and all rights to
indemnification which Executive may be entitled to under the laws of the State of Florida or the Certificate of Incorporation and By-laws of the Company. To the extent permitted under the laws of the State of Florida, and the Company’s
Certificate of Incorporation and By-Laws, all expenses, including reasonable attorneys fees, incurred by Executive in defending any civil, criminal, administrative or investigative action, shall upon request by Executive, be paid and advanced by the
Company in advance of the final disposition of such action, suit or proceeding. 

  

	7.2.	Director and Officers Liability Insurance. During the Term, unless the Executive otherwise consents, the Company will maintain directors’ and officers’
liability insurance in an amount not less than $5,000,000, and Executive shall at all times be one of the named insured under such coverage. 

 Article 8 Miscellaneous. 
  

	8.1.	Governing Law. This Agreement shall be governed by Florida law without regard to the conflicts of laws principles thereof. 

 

	8.2.	Non-Contravention. Executive represents and warrants that the execution, delivery and performance of this Agreement do not and will not contravene, conflict with
or otherwise violate the terms of any written or oral agreement among Executive and one or more third parties. 

  

	8.3.	Arbitration. Disputes between the parties arising under or with respect to this Agreement shall be submitted to arbitration in Hillsborough County, Florida by a
single arbitrator under the rules of the American Arbitration Association, and the arbitration award shall be binding upon the parties and enforceable in any court of competent jurisdiction. The cost of arbitration, including counsel fees, shall be
borne by the Company unless the arbitrator determines that the Executive’s position was frivolous and without reasonable foundation. 

  
 Page 7 of 8

	8.4.	Notices. Any notice or communication to be given under the terms of this Agreement shall be in writing and delivered in person or deposited, certified or
registered, in the United States mail, postage prepaid, addressed as follows: 

  

							
	If to Company:	  	Dais-Analytic Corporation	  	If to Executive:	  	Patricia K. Tangredi
		  	11552 Prosperous Drive	  		  	10416 Pontofino Circle
		  	Odessa, Florida 33556	  		  	Trinity, FL 34655
		  	Attn: President	  		  	

 or at such other address as either party may from time to time designate by notice hereunder.
Notices shall be effective upon delivery in person or, if mailed, at midnight on the third business day after the date of mailing. 
  

	8.5.	Modifications and Amendments. This Agreement shall not be modified, altered or amended except by a written agreement signed by the parties hereto.

  

	8.6.	Entire Agreement. This Agreement together with the documents referred to herein or contemplated hereby constitute and embody the full and complete understanding
and agreement of the parties hereto with respect to the subject matter hereof and supersede all prior understandings or agreements whether oral or in writing with respect to the subject matter hereof. 

 

	8.7.	Benefit and Binding Effect. This Agreement shall be binding upon and inure to the benefit of Company and its successors and assigns, including any corporation,
person or other entity which may acquire all or substantially all of the business of Company or any other corporation with or into which Company is consolidated or merged, and Executive and his heirs, executors, administrators and legal
representatives, provided, however, that the obligations of Executive hereunder may not be delegated or assigned. 

  

	8.8.	Severability. If any portion of this Agreement may be held to be invalid or unenforceable for any reason whatsoever, it is agreed that said invalidity or
unenforceability shall not affect the other portions of this Agreement and that the remaining covenants, terms and conditions, or portions thereof, shall remain in full force and effect, and any court of competent jurisdiction may so modify the
objectionable provisions as to make it valid, reasonable and enforceable 

  

	8.9.	Headings; Interpretation. The section headings used herein are for convenience and reference only and are not intended to define, limit or describe the scope or
intent of any provision of this Agreement. When used in this Agreement, the term “including” shall mean without limitation by reason of enumeration. Words used herein in the singular shall include the plural. 

 

	8.10.	Waiver. The failure of either party to insist, in any one or more instances, upon strict performance of any of the terms or conditions of this Agreement shall
not be construed as a waiver or a relinquishment of any right granted hereunder or of the future performance of any such term, covenant or condition, but the obligations of either party with respect thereto shall continue in full force and effect.

  

	8.11.	Counterparts. This Agreement may be executed in any number of counterparts, each of whom shall be deemed a duplicate original. 

In Witness Whereof, the parties have executed this Agreement as of the date first written above. 

 

							
	EXECUTIVE:	 		 	DAIS ANALYTIC CORPORATION
				
	 /s/ Patricia K. Tangredi
	 		 	By:	 	 /s/ Ray Kazyaka, Sr.

	Patricia K. Tangredi	 		 	Ray Kazyaka, Sr.
		 		 	Board Member – Dais Analytic Corporation

  
 Page 8 of 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00188-of-00352.parquet"}]]